Evidence for systems that carry regulated work.
Kivo documents submission structures, content placeholders, a blinded-or-unblinded toggle, tracking spreadsheets, and export to publishing partners or software. A handoff still needs an approved content inventory, artifact-level blinding state, immutable transfer manifest, and receiver reconciliation before it can be treated as complete or appropriately disclosed.
Scilife describes controlled printing and reconciliation alongside its document-management workflows. A printed copy still needs a durable identity, point-of-use owner, issuance history, reconciliation state, and retirement evidence before teams can know which instruction was available for regulated work.
Generis presents CARA as one governed platform spanning regulatory, quality, safety, and clinical processes, with shared records and audit trails. The same underlying record can reduce re-entry, but each configured process still needs intended-use, migration, access, workflow, calculation, report, interface, and exception evidence before the organization can rely on it for regulated work.
Scilife describes controlled printing and reconciliation alongside its document-management workflows. A printed copy still needs a durable identity, point-of-use owner, issuance history, reconciliation state, and retirement evidence before teams can know which instruction was available for regulated work.
Generis presents CARA as one governed platform spanning regulatory, quality, safety, and clinical processes, with shared records and audit trails. The same underlying record can reduce re-entry, but each configured process still needs intended-use, migration, access, workflow, calculation, report, interface, and exception evidence before the organization can rely on it for regulated work.
EMA says the PLM web-based electronic Application Form becomes mandatory for human Centrally Authorised Product variation submissions on September 1, 2026, with justified technical exceptions for continued interactive-PDF use. Regulatory operations need to preserve the applicable form path, impediment, support evidence, submission package, and receipt outcome as separate controlled facts.
ArisGlobal presents LifeSphere Regulatory as an end-to-end environment for regulatory data, content, submissions, labeling, planning, tracking, and health-authority interactions. Connecting those records can improve oversight, but an incoming question, an outgoing response, a promised action, and completion evidence still need distinct identities, owners, dates, and approval states.
FDA labels Draft CVM GFI #256B as not for implementation and says it contains nonbinding recommendations for comment. The draft describes a future enforcement policy for certain animal drugs compounded from bulk substances in federally registered facilities, while stating that FDA generally would not intend to exercise enforcement discretion for current good manufacturing practice violations at those facilities.
ETQ presents audit management, quality events, nonconformance handling, CAPA, change, and release work in a configurable quality platform. Linking those workflows can reduce handoff loss, but an audit finding, immediate containment, systemic corrective action, and effectiveness conclusion remain different evidence states.
Electronic quality systems coordinate controlled documents, training, events, CAPA, change, audits, suppliers, complaints, and management review without becoming the quality system themselves.
Read the market record →Regulatory information management connects structured product records with activities, registrations, dossiers, correspondence, commitments, and post-approval change.
Read the market record →Buyers need version-specific evidence, configuration accountability, controlled change, traceability, and a clear line between provider deliverables and customer responsibility.
Read the market record →A product or process change may affect quality events, regulatory commitments, submissions, labeling, training, supplier records, and inspection evidence. Architecture matters at the handoffs.
Read the market record →Regulatory operations teams need controlled form-version selection, documented transition dates, testing, and reconciliation with PMS and PLM eAF workflows.
Sponsors and regulatory operations teams should recheck supported package versions, controlled vocabulary, technical validation, release timing, and internal change-assessment evidence.
The release increases the testability and reuse of some authority product data but does not remove the need for internal master-data ownership, reconciliation, and controlled regulatory workflows.
Medical-device organizations need controlled data ownership and change propagation across quality, product, certificate, operator, and regulatory records.
Buyers should evaluate intended-use, risk, supplier evidence, testing, change control, and customer responsibilities instead of relying on an unbounded validated-software claim.
Device manufacturers must align their controlled quality systems and inspection evidence; software alignment can support but cannot establish organizational compliance.
The research connects the provider market, normalized capabilities, authority records, operating domains, and source limitations rather than presenting a score or universal winner.
Read the report →